Carfilzomib Works Well As Salvage Treatment; Momentum Builds For Frontline Role
This article was originally published in The Pink Sheet Daily
Executive Summary
Small study of Onyx' proteasome inhibitor shows potential for replacing Velcade in combination with Revlimid and dexamethasone in newly diagnosed multiple myeloma patients.